Open Orphan (ORPH) Share Price, News & Analysis

Company Overview

Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides pre­clinical and early clinical research services; sales and marketing services; and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company is headquartered in London, the United Kingdom.

Key Stats

• Today's Range: 9.50 to 10.38
• 50-Day Range: 10 to 10
• 52-Week Range: 8.68 to 25
• Volume: 652,639 shs
• Average Volume: 1.56 million shs
• Market Capitalization: £67.09 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ORPH Stock Analysis - Frequently Asked Questions

How have ORPH shares performed this year?

Open Orphan's stock was trading at GBX 10 at the beginning of 2024. Since then, ORPH shares have increased by 0.0% and is now trading at GBX 10.
View the best growth stocks for 2024 here.

How do I buy shares of Open Orphan?

Shares of ORPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Open Orphan own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Open Orphan investors own include HSBC (HSBA), Royal Dutch Shell (RDSB), Cassava Sciences (SAVA), Barclays (BARC), EQTEC (EQT), Grafton Group (GFTU) and Lloyds Banking Group (LLOY).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: LON:ORPH
• CUSIP: N/A
• CIK: N/A
• Web: www.openorphan.com
• Phone: 353 1 644 0007
• Fax: N/A
• Employees: 179
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 13.33
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 10.88
• Current Ratio: 1.19
• Quick Ratio: 1.16

Sales & Book Value

• Annual Sales: £34.71 million
• Price / Sales: 1.93
• Cash Flow: GBX 2.40 per share
• Price / Cash Flow: 4.17
• Book Value: GBX 3.10 per share
• Price / Book: 3.23

Miscellaneous

• Outstanding Shares: 670,929,000
• Free Float: N/A
• Market Cap: £67.09 million
• Optionable: Not Optionable
• Beta: N/A